Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud ’s Phenomenon
In this report, we present a patient with Raynaud’s phenomenon refractory to standard therapies whose symptoms resolved after treatment with BTX-A. Follow-up with the patient after one and five years showed no relapse or recurrence of symptoms.
J Drugs Dermatol. 2019;18(9):943-945.
PMID: 31524993 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
More News: Brain | Calcium | Dermatology | Lupus | Neurology | Raynaud's Phenomenom | Scleroderma | Skin